LSIPR 50 2018: Elaine Waller

Name: Elaine Waller

Organisation: Seattle Genetics

Position: Executive Vice President, Regulatory Affairs

Elaine Waller joined Seattle Genetics in September 2008, bringing with her more than 20 years of experience in regulatory affairs and clinical research.

During her tenure, the US Food and Drug Administration accepted for filing a supplemental Biologics License Application (BLA) for a Seattle Genetics drug to fight advanced Hodgkin lymphoma.